Glenmark Life Sciences: A Promising Midcap Company with Strong Performance and Potential for Growth
Glenmark Life Sciences, a midcap pharmaceutical company, has been in the spotlight as its stock price reached an all-time high on July 3rd, 2024. The company's stock has been performing well, outperforming the sector and showing a positive trend in its moving averages. With a strong focus on research and development, Glenmark Life Sciences is a promising player in the pharmaceutical industry.
Glenmark Life Sciences, a midcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on July 3rd, 2024. The company's stock has been performing well, with a current price of Rs 903, just 0.13% away from its 52-week high of Rs 904.2.
According to MarketsMOJO, a leading stock market analysis platform, the stock is currently rated as 'Hold'. However, Glenmark Life Sciences has outperformed the sector by 1.41% today, with an intraday high of Rs 903, which is 2.1% higher than its previous close.
The company's moving averages also show a positive trend, with Glenmark Life Sciences trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a strong performance and potential for future growth.
In the past year, Glenmark Life Sciences has shown a remarkable 60.45% increase in its stock price, outperforming the Sensex's performance of 22.63%. This further highlights the company's strong position in the market and its potential for continued success.
Glenmark Life Sciences, with its focus on research and development, has established itself as a key player in the pharmaceutical industry. Its consistent growth and strong performance make it a promising midcap company to watch out for in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
